Guidance for Industry Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes

First Page		Document Content
Anatomy Hemoglobins Emergency medicine Haemoglobin-based oxygen carriers Blood substitutes Blood Red blood cell Alpha-thalassemia Anemia Medicine Biology Hematology		Guidance for Industry Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 62,38 KB Share Document on Facebook

	When should blood transfusions be given after cardiac surgery? DocID: YDjv - View Document
	Microsoft PowerPoint - HKABTH 2003 v3 DocID: UtCE - View Document
	Guidance for In Criteria for Safety and E Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes DRAFT GUIDANCE This guidance is being distributed for comment purposes only. DocID: AgvY - View Document
	Guidance for Industry Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes DocID: j7IW - View Document
	Review of Publicly Available Reports of Adverse Events Associated with HBOCs Toby Silverman, M.D., Laurence Landow, M.D., Hon Sum Ko, M.D., and Kimberly Lindsey, M.D. Office of Blood Research and Review, CBER, FDA April DocID: iTnQ - View Document